Ocinaplon
Alternative Names: CL 273547; Ocinaplon sustained releaseLatest Information Update: 15 Nov 2005
At a glance
- Originator Wyeth
- Developer DOV Bermuda; Wyeth
- Class Anxiolytics; Pyrimidines; Small molecules
- Mechanism of Action GABA A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Generalised anxiety disorder
Most Recent Events
- 03 Nov 2005 Discontinued - Phase-III for Generalised anxiety disorder in USA (PO)
- 25 Aug 2005 Suspended - Phase-III for Generalised anxiety disorder in USA (PO)
- 25 Nov 2004 Phase-III clinical trials in Generalised anxiety disorder in USA (PO)